CareDx Debt to Equity Ratio 2013-2024 | CDNA

Current and historical debt to equity ratio values for CareDx (CDNA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CareDx debt/equity for the three months ending March 31, 2024 was 0.00.
CareDx Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $0.20B $0.26B 0.77
2023-12-31 $0.21B $0.26B 0.79
2023-09-30 $0.11B $0.39B 0.27
2023-06-30 $0.11B $0.41B 0.27
2023-03-31 $0.11B $0.42B 0.26
2022-12-31 $0.11B $0.43B 0.26
2022-09-30 $0.11B $0.44B 0.25
2022-06-30 $0.10B $0.44B 0.22
2022-03-31 $0.09B $0.46B 0.20
2021-12-31 $0.10B $0.47B 0.22
2021-09-30 $0.09B $0.47B 0.19
2021-06-30 $0.08B $0.48B 0.16
2021-03-31 $0.07B $0.47B 0.15
2020-12-31 $0.09B $0.28B 0.33
2020-09-30 $0.09B $0.27B 0.32
2020-06-30 $0.08B $0.26B 0.32
2020-03-31 $0.06B $0.10B 0.55
2019-12-31 $0.05B $0.10B 0.53
2019-09-30 $0.05B $0.10B 0.49
2019-06-30 $0.05B $0.09B 0.53
2019-03-31 $0.03B $0.10B 0.34
2018-12-31 $0.04B $0.10B 0.36
2018-09-30 $0.05B $0.04B 1.06
2018-06-30 $0.05B $0.03B 1.76
2018-03-31 $0.05B $0.03B 1.36
2017-12-31 $0.09B $-0.01B -15.04
2017-09-30 $0.08B $0.00B -430.10
2017-06-30 $0.07B $0.01B 5.49
2017-03-31 $0.07B $0.02B 4.41
2016-12-31 $0.06B $0.02B 2.88
2016-09-30 $0.07B $0.04B 1.78
2016-06-30 $0.07B $0.03B 2.09
2016-03-31 $0.03B $0.02B 1.39
2015-12-31 $0.03B $0.03B 0.89
2015-09-30 $0.03B $0.03B 0.75
2015-06-30 $0.03B $0.04B 0.67
2015-03-31 $0.02B $0.04B 0.60
2014-12-31 $0.02B $0.04B 0.48
2014-09-30 $0.02B $0.04B 0.53
2014-06-30 $0.04B $-0.00B -24.19
2014-03-31 $0.03B $-0.02B -1.66
2013-12-31 $0.03B $-0.02B -1.64
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.02B $-0.01B -1.82
Sector Industry Market Cap Revenue
Medical Medical Services $0.942B $0.280B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $115.971B 14.14
Cencora (COR) United States $44.597B 17.39
ICON (ICLR) Ireland $27.199B 25.68
DiDi Global (DIDIY) China $17.303B 0.00
Avantor (AVTR) United States $14.163B 20.85
CochLear (CHEOY) Australia $14.103B 0.00
Viatris (VTRS) United States $14.098B 4.21
Revvity (RVTY) United States $13.345B 23.41
Medpace Holdings (MEDP) United States $13.053B 42.95
Natera (NTRA) United States $13.015B 0.00
Charles River Laboratories (CRL) United States $11.242B 21.52
Solventum (SOLV) United States $9.430B 0.00
Sonic Healthcare (SKHHY) Australia $8.373B 0.00
HealthEquity (HQY) United States $6.385B 40.99
Bausch + Lomb (BLCO) Canada $5.974B 23.92
Organon (OGN) United States $5.395B 5.12
Doximity (DOCS) United States $5.233B 36.65
PACS (PACS) United States $4.921B 0.00
Life Times (LTH) United States $4.146B 43.44
Sotera Health (SHC) United States $3.705B 18.18
Surgery Partners (SGRY) United States $3.692B 33.78
GoodRx Holdings (GDRX) United States $3.189B 121.43
Agilon Health (AGL) United States $2.834B 0.00
Progyny (PGNY) United States $2.646B 45.56
AMN Healthcare Services Inc (AMN) United States $2.167B 8.59
Premier (PINC) United States $2.051B 8.78
BrightSpring Health Services (BTSG) United States $2.004B 0.00
Alignment Healthcare (ALHC) United States $1.925B 0.00
Teladoc Health (TDOC) United States $1.542B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.467B 0.00
Establishment Labs Holdings (ESTA) $1.251B 0.00
GeneDx Holdings (WGS) United States $0.831B 0.00
InnovAge Holding (INNV) United States $0.825B 0.00
Embecta (EMBC) United States $0.760B 5.16
Auna S.A (AUNA) Luxembourg $0.657B 0.00
Pediatrix Medical (MD) United States $0.633B 6.71
COMPASS Pathways (CMPS) United Kingdom $0.499B 0.00
Sharecare (SHCR) United States $0.497B 0.00
Enhabit (EHAB) United States $0.476B 47.45
Sonida Senior Living (SNDA) United States $0.407B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.335B 6.27
DocGo (DCGO) United States $0.314B 17.17
LifeMD (LFMD) United States $0.274B 0.00
MultiPlan (MPLN) United States $0.258B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
Beauty Health (SKIN) United States $0.221B 0.00
Biodesix (BDSX) United States $0.203B 0.00
Ascend Wellness Holdings (AAWH) United States $0.194B 0.00
So-Young (SY) China $0.100B 48.51
Pono Capital Two (PTWO) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.043B 5.82
Co-Diagnostics (CODX) United States $0.041B 0.00
Oncology Institute (TOI) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.034B 0.00
Nutex Health (NUTX) United States $0.034B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.024B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
TRxADE HEALTH (MEDS) United States $0.021B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00